Search results
Results From The WOW.Com Content Network
Mehta became the CEO and MD of Hindustan Unilever in October 2013, and in June 2018 was appointed chairman. He also heads Unilever's business in South Asia, as cluster president encompassing businesses in India, Pakistan, Bangladesh, Sri Lanka and Nepal. [5] Mehta is a member of the Unilever leadership executive, its global executive board. [6]
Schumacher began his career at Unilever. [1] He was previously the CEO of the Dutch dairy co-operative FrieslandCampina from 2018 until 2023. [1] [2] [3] Before that, he worked at Heinz and was based in China for four years. [2] Schumacher has been a non-executive director of Unilever from October 2022 until his appointment as its CEO in July ...
Alan Jope CBE (born 1964) is a British businessman. He served as CEO of Unilever from January 2019 until June 2023, succeeding Paul Polman. [1] Upon stepping down as CEO of Unilever, Jope was succeeded by Hein Schumacher who took on the role from July 2023.
Hein Schumacher became Unilever's CEO last July. ... the London-listed consumer giant that makes Magnum ice cream and Dove soap is planning to sell off food brands worth €1 billion in cumulative ...
He was the chief executive officer (CEO) of the British/Dutch consumer goods company Unilever. [3] Polman is also the co-author (with Andrew Winston) of Net Positive: How Courageous Companies Thrive by Giving More Than They Take. [4]
During his 10-year stint as CEO of Unilever, from 2009 to 2019, Paul Polman transformed the consumer products giant into a model of sustainable sourcing, production, and profits.
In January 2019, Alan Jope succeeded Paul Polman as the chief executive officer. [111] The chief financial officer, Graeme Pitkethly, [112] is executive director. Jope will be proposed as joint executive director at Unilever's 2019 AGM. [113] Previously, Paul Polman was CEO for ten years, succeeding Patrick Cescau in 2009. [114]
The decision comes after the CEO came under severe criticism over a failed takeover bid of drugmaker GSK Plc's (NYSE: GSK) consumer health unit worth £50 billion ($53 billion), Bloomberg reported.